Menu
← Oncology Approval Tracker
FDA DECISION ·
Qinlock
ripretinib · Deciphera Pharmaceuticals
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with advanced gastrointestinal stromal tumor previously treated with at least three kinase inhibitors, including imatinib.
LAMPGEN ANALYSIS
Why it matters
Added a later-line KIT and PDGFRA inhibitor for heavily pretreated disease.
What research teams should watch
Reconcile prior kinase inhibitor sequences and plan dermatology and cardiac monitoring.
PRIMARY RECORDS